May 2023.
Said to be the world’s first, the tool is designed to engage and educate cancer patients on their clinical journey. Dave provides oncology-specific, personalized information instantaneously, the company claims. The goal is to improve the quality of care and life for patients worldwide, executives said in a press release.
To date, Dave has been tested by more than 10,000 people with cancer.
“Dave has received tremendous gratitude from users and has been proven valuable by the frequent patient use and the many follow-up interactions,” Irad Deutsch, co-founder and chief technology officer of Belong.life, said in a press release.
Driven by machine learning and natural language processing, Dave was trained on seven years’ worth of data, including patient-provider and peer-to-peer interactions. The data came from Belong’s Beating Cancer Together app, which the company says is the world’s largest social and professional network for cancer patients and caregivers. Dave retains a long-term memory of previous conversations to facilitate continuous communication across chat sessions.
